273 related articles for article (PubMed ID: 8266923)
1. Effect of intravenous immunoglobulin on inhibition of fibrinogen binding to platelets by sera from patients with immune thrombocytopenia.
Kamiyama M; Yoshimura Y; Chen K; Arkel YS
Am J Hematol; 1993 Oct; 44(2):77-84. PubMed ID: 8266923
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet GPIIb/IIIa binding to fibrinogen by serum factors: studies of circulating immune complexes and platelet antibodies in patients with hemophilia, immune thrombocytopenic purpura, human immunodeficiency virus-related immune thrombocytopenic purpura, and systemic lupus erythematosus.
Kamiyama M; Arkel YS; Chen K; Shido K
J Lab Clin Med; 1991 Mar; 117(3):209-17. PubMed ID: 2002277
[TBL] [Abstract][Full Text] [Related]
3. Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients.
Nardi M; Karpatkin S
J Exp Med; 2000 Jun; 191(12):2093-100. PubMed ID: 10859334
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the expression of autoantibodies against platelet membrane glycoprotein and therapeutic effect in primary immune thrombocytopenia].
Liu XF; Xue F; Zhang L; Zhou XL; Liu YZ; Liu W; Chen YF; Huang YT; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):610-3. PubMed ID: 23906456
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG.
Liang SX; Pinkevych M; Khachigian LM; Parish CR; Davenport MP; Chong BH
Blood; 2010 Sep; 116(11):1958-60. PubMed ID: 20566900
[TBL] [Abstract][Full Text] [Related]
7. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.
Nardi MA; Liu LX; Karpatkin S
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7589-94. PubMed ID: 9207136
[TBL] [Abstract][Full Text] [Related]
8. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.
Pidard D; Frelinger AL; Bouillot C; Nurden AT
Eur J Biochem; 1991 Sep; 200(2):437-47. PubMed ID: 1889410
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.
Hansen RJ; Balthasar JP
Blood; 2002 Sep; 100(6):2087-93. PubMed ID: 12200371
[TBL] [Abstract][Full Text] [Related]
10. Differences between platelet and microparticle glycoprotein IIb/IIIa.
Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K
Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594
[TBL] [Abstract][Full Text] [Related]
11. Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens.
Fujisawa K; Tani P; McMillan R
Blood; 1993 Mar; 81(5):1284-9. PubMed ID: 7680243
[TBL] [Abstract][Full Text] [Related]
12. The serology and immunochemistry of HIV-induced platelet-bound immunoglobulin.
Klaassen RJ; van der Lelie J; Vlekke AB; Weigel HM; Eeftinck Schattenkerk JK; Reiss P; von dem Borne AE
Blut; 1989 Jul; 59(1):75-81. PubMed ID: 2665874
[TBL] [Abstract][Full Text] [Related]
13. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
Karpatkin S; Nardi MA; Hymes KB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
[TBL] [Abstract][Full Text] [Related]
14. GPIIIa(90-102) and GPIIIa(631-653) epitopes as markers of conformational changes occurring during the activation of the glycoprotein IIb/IIIa complex.
Niewiarowska J; Cierniewski CS
Eur J Biochem; 1994 Sep; 224(3):803-9. PubMed ID: 7523118
[TBL] [Abstract][Full Text] [Related]
15. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
[TBL] [Abstract][Full Text] [Related]
16. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura.
Bettaieb A; Fromont P; Louache F; Oksenhendler E; Vainchenker W; Duédari N; Bierling P
Blood; 1992 Jul; 80(1):162-9. PubMed ID: 1611083
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrinogen antibody mediates fibrinogen binding to platelet membrane glycoprotein IIb-IIIa.
Mohri H; Tanabe J; Fujita H; Kanamori H; Ohkubo T
Br J Haematol; 1993 Oct; 85(2):341-7. PubMed ID: 8280606
[TBL] [Abstract][Full Text] [Related]
18. Activation-independent exposure of the GPIIb-IIIa fibrinogen receptor.
Kouns WC; Jennings LK
Thromb Res; 1991 Aug; 63(3):343-54. PubMed ID: 1957276
[TBL] [Abstract][Full Text] [Related]
19. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J
Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688
[TBL] [Abstract][Full Text] [Related]
20. Detection of an epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets.
Khaspekova SG; Vlasik TN; Byzova TV; Vinogradov DV; Berndt MC; Mazurov AV
Br J Haematol; 1993 Oct; 85(2):332-40. PubMed ID: 7506568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
